Latest Oxaliplatin Stories
Long term results of the randomized phase III EORTC intergroup trial 40983 were recently reported in The Lancet Oncology.
The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could not stop the disease from progressing.
In a retrospective study recently online by The Oncologist, Jason Faris, M.D., Medical Oncologist at the Massachusetts General Hospital Cancer Center in Boston, and colleagues described their
- An imitative word; an onomatopoetic word.